NovaBridge Biosciences
- NBP
- NASDAQ
- Biotechnology
- Immuno-Oncology
- Bispecific Antibodies
- Cancer Therapeutics
$1.30
Today +3.57%Quote Oct 19, 2026, 04:59 PM UTC
−22.70%over the last month
Max drawdown −22.7%From 1-month high −22.7%3 months −29.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About NovaBridge Biosciences
NovaBridge Biosciences, a biotechnology firm, primarily focuses on pioneering immuno-oncology treatments for cancer patients within the United States.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
30
Founded
2014
Market value
$346.3M
Quote Oct 19
Floor
$1.29
0.9% below price
Resistance
$1.35
3.2% above price
Price vs analyst targets
11 analysts
Lowest target
$7.00Highest target
$9.00
$7.00Highest target
$9.00
- Price $1.30
- Average target $8.25
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 532% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NBPPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free